Spirometer-dependence of vital capacity in ALS: Validation of a portable device in 52 patients

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 6, Issue 1 SUPPL. 1, 2005, Pages 239-245

  Couratier, Philippe ^a   Vincent, François ^a   Torny, Frederic ^a   Lacoste, Mathieu ^a   Melloni, Boris ^a   Lemaire, François ^a   Antonini, Marie Therese ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Amyotrophic lateral sclerosis; Spirometer; Vital capacity

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DEVICE; FEMALE; FOLLOW UP; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PNEUMOTACHYGRAPHY; PRIORITY JOURNAL; SPIROMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS; VITAL CAPACITY; ANALYTIC METHOD; CORRELATION FUNCTION; DATA ANALYSIS; DISEASE COURSE; FLOW MEASUREMENT; MEDICAL INSTRUMENTATION; OPERATOR; POPULATION RESEARCH; RELIABILITY; RISK ASSESSMENT; SPIROMETER; TRAINING;

AMYOTROPHIC LATERAL SCLEROSIS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SPIROMETRY; VITAL CAPACITY;

EID: 29244445795     PISSN: 14660822     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820510043244     Document Type: Article

References (24)

1. Kaplan, L.M. and Hollander, D. (1994) Respiratory dysfunction in amyotrophic lateral sclerosis. Clin Chest Med, 15, pp. 675-681.
2. Lyall, R.A. and Donaldson, N. and Polkey, M.I. and Leigh, P.N. and Moxham, J. (2001) Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain, 124, pp. 2000-2013.
3. Fitting, J.W. and Paillex, R. and Hirt, L. and Aebischer, P. and Schluep, M. (1999) Sniff nasal pressure: A sensitive respiratory test to assess progression of ALS. Ann Neurol, 46, pp. 887-893.
4. Mendoza, M. and Moore, D. and Gelinas, D. and Miller, R.A. (Dec. 2000) Comparison of MIP and FVC in ALS. Eleventh Annual Symposium on ALS/NMD, 1(Suppl 3), pp. 39.
5. Miller, R.G. and Rosenberg, J.A. and Gelinas, D.F. and Mitsumoto, H. and Newman, D. and Sufit, R. et al (1999) Practice parameter: The care of the patient with ALS (an evidence based review). Report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology, 52, pp. 1311-1323.
6. Miller, R.G. and Moore, D.H. and Gelinas, D.F. and Dronsky, V. and Mendoza, M. and Barohn, R.J. et al (2001) Phase III randomised trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology, 56, pp. 843-848.
7. The BDNF study group. (1999) A controlled trial of recombinant methionyl human BDNF in ALS. Neurology, 52, pp. 1423-1427.
8. Griggs, R.C. (1990) The use of pulmonary function testing as a quantitative measurement for therapeutic trials. Muscle Nerve, 13(suppl), pp. S30-S34.
9. Stembler, N. and Charatan, M. and Cederbaum, J.M. and the ALS CTNF Treatment Study Group. (1998) Prognostic indicators of survival in ALS. Neurology, 50, pp. 66-72.
10. Bradley, W.G. and Miller, R.G. and the BDNF Study Group. (1999) Phase III trial of subcutaneous recombinant methionyl human BDNF in patients with ALS. Neurology, 52, pp. 1427-1433.
11. American Thoracic Society. (1987) Standardization of spirometry (1987 update). Am Rev Respir Dis, 136, pp. 1285-1296.
12. American Thoracic Society Statement. (1994) Standardization of spirometry (1994 update). Am J Resp Crit Care Med, 152, pp. 1107-1136.
13. Bland, J.M. and Altman, D.G. (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 8, pp. 307-310.
14. Fritzgerald, M.X. and Smith, A.A. and Garnsler, E.A. (1973) Evaluation of 'electronic' spirometers. N Engl J. Med, 289, pp. 1283-1286.
15. Gardner R.M. and Hankinson, J.L. and West, B.J. (1980) Evaluating commercially available spirometers. Am Rev Respir Dis, 121, pp. 73-82.
16. Nelson, S.B. and Gardner, R.M. and Crapo, R.O. and Jensen, R.L. et al (1990) Performance evaluation of contemporary spirometers. Chest, 97, pp. 288-297.
17. Hayot, M. and Reneaux, C. and Barabe, P. and Préfaut, C. and (1996) Les spiromètres portables, gadgets peu fiables ou véritables outils professionnels? Un essai comparatif pour guider vos choix. Bulletin Soc de Pneumologie de Langue Française 4
18. Quanjer, P.H. and Tammeling, G.J. and Cotes, O.F. and Pedersen, O.F. and Peslin, R. and Yemault, J.C. et al (1993) Lung volumes and forced ventilatory flows. Report of working party. Standardisation of lung function tests, European community for steel and coal. Eur Resp J, 6(Suppl 16), pp. 5-40.
19. Sanjak, M. and Salachas, P. and Frija-Orvoen, F. and Theys, P. and Hutchinson, D. and Verheijde, J. et al (2000) Prospective quality control of VC as primary end point in international multicentre therapeutic trial of xaliproden in ALS. Eleventh Annual Symposium on ALS/ NMD, Dec. 2000; ALS, 1(Suppl 3), pp. 59-60.
20. Polkey, M.I. and Lyall, R.A. and Moxham, J. and Leigh, P.N. et al (1999) Respiratory aspects of neurological disease. J Neurol Neurosurg Psychiatry, 66, pp. 5-15.
21. Fallat, R.J. and Jewitt, B. and Bass, M. and Kamm, B. and Norris, F. (1979) Spirometry in ALS. Arch Neurol, 36, pp. 74-80.
22. Shiffman, P.L. and Belch, J.M. (1993) Pulmonary function at diagnosis of amyotrophic lateral sclerosis: Rate of deterioration. Chest, 103, pp. 508-513.
23. Enright, P.L. and Hyatt, R.E.(1987) Office spirometry. In A practical guide to the selection and use of spirometers. Lea and Febiger Edit., Philadelphia. (pp. 253).
24. Gardner, R.M. and Clausen, J.L. and Epler, G. and Hankinson, J.L. and Permutt, S. and Plummer, A.L. et al (1986) Pulmonary function laboratory personnel qualifications. Am Rev Respir Dis, 134, pp. 6232-6624.